View Item 

Show simple item record

mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease
dc.contributor.authorWang, Jintao
dc.contributor.authorTran, Jennifer
dc.contributor.authorWang, Hui
dc.contributor.authorGuo, Chiao
dc.contributor.authorHarro, David
dc.contributor.authorCampbell, Andrew D.
dc.contributor.authorEitzman, Daniel T.
dc.date.accessioned2016-09-17T23:54:50Z
dc.date.available2017-11-01T15:31:29Zen
dc.date.issued2016-08
dc.identifier.citationWang, Jintao; Tran, Jennifer; Wang, Hui; Guo, Chiao; Harro, David; Campbell, Andrew D.; Eitzman, Daniel T. (2016). "mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease." British Journal of Haematology 174(3): 461-469.
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.urihttps://hdl.handle.net/2027.42/133604
dc.publisherWiley Periodicals, Inc.
dc.subject.othermechanistic target of rapamycin
dc.subject.otheranaemia
dc.subject.othersickle cell disease
dc.subject.othersirolimus
dc.subject.otherstroke
dc.titlemTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133604/1/bjh14057.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133604/2/bjh14057_am.pdf
dc.identifier.doi10.1111/bjh.14057
dc.identifier.sourceBritish Journal of Haematology
dc.identifier.citedreferenceNey, P.A. ( 2011 ) Normal and disordered reticulocyte maturation. Current Opinion in Hematology, 18, 152 – 157.
dc.identifier.citedreferenceGBD 2013 Mortality and Causes of Death Collaborators ( 2015 ) Global, regional, and national age‐sex specific all‐cause and cause‐specific mortality for 240 causes of death, 1990‐2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385, 117 – 171.
dc.identifier.citedreferenceJung, C.H., Ro, S.H., Cao, J., Otto, N.M. & Kim, D.H. ( 2010 ) mTOR regulation of autophagy. FEBS Letters, 584, 1287 – 1295.
dc.identifier.citedreferenceKean, L.S., Manci, E.A., Perry, J., Balkan, C., Coley, S., Holtzclaw, D., Adams, A.B., Larsen, C.P., Hsu, L.L. & Archer, D.R. ( 2003 ) Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood, 102, 4582 – 4593.
dc.identifier.citedreferenceKnight, Z.A., Schmidt, S.F., Birsoy, K., Tan, K. & Friedman, J.M. ( 2014 ) A critical role for mTORC1 in erythropoiesis and anemia. eLife, 3, e01913.
dc.identifier.citedreferenceKoury, M.J., Koury, S.T., Kopsombut, P. & Bondurant, M.C. ( 2005 ) In vitro maturation of nascent reticulocytes to erythrocytes. Blood, 105, 2168 – 2174.
dc.identifier.citedreferenceLanzkron, S., Strouse, J.J., Wilson, R., Beach, M.C., Haywood, C., Park, H., Witkop, C., Bass, E.B. & Segal, J.B. ( 2008 ) Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Annals of Internal Medicine, 148, 939 – 955.
dc.identifier.citedreferenceLiu, Y., Pop, R., Sadegh, C., Brugnara, C., Haase, V.H. & Socolovsky, M. ( 2006 ) Suppression of Fas‐FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood, 108, 123 – 133.
dc.identifier.citedreferenceLuo, W., Campbell, A., Wang, H., Guo, C., Bradley, K., Wang, J. & Eitzman, D.T. ( 2012 ) P‐selectin glycoprotein ligand‐1 inhibition blocks increased leukocyte‐endothelial interactions associated with sickle cell disease in mice. Blood, 120, 3862 – 3864.
dc.identifier.citedreferenceLuo, W., Su, E.J., Wang, J., Wang, H., Guo, C., Pawar, A., Campbell, A.D., Lawrence, D.A. & Eitzman, D.T. ( 2014 ) Increased stroke size following MCA occlusion in a mouse model of sickle cell disease. Blood, 123, 1965 – 1967.
dc.identifier.citedreferenceMankelow, T.J., Griffiths, R.E., Trompeter, S., Flatt, J.F., Cogan, N.M., Massey, E.J. & Anstee, D.J. ( 2015 ) Autophagic vesicles on mature human reticulocytes explain phosphatidylserine‐positive red cells in sickle cell disease. Blood, 126, 1831 – 1834.
dc.identifier.citedreferenceMischiati, C., Sereni, A., Lampronti, I., Bianchi, N., Borgatti, M., Prus, E., Fibach, E. & Gambari, R. ( 2004 ) Rapamycin‐mediated induction of gamma‐globin mRNA accumulation in human erythroid cells. British Journal of Haematology, 126, 612 – 621.
dc.identifier.citedreferenceNagel, R.L. ( 1998 ) A knockout of a transgenic mouse–animal models of sickle cell anemia. New England Journal of Medicine, 339, 194 – 195.
dc.identifier.citedreferenceOnyike, A.E., Ohene‐Frempong, K. & Horiuchi, K. ( 1995 ) Sickling in vitro at venous and arterial oxygen tensions of reticulocytes from patients with sickle cell disease. Biochemical and Biophysical Research Communications, 211, 504 – 510.
dc.identifier.citedreferencePaszty, C., Brion, C.M., Manci, E., Witkowska, H.E., Stevens, M.E., Mohandas, N. & Rubin, E.M. ( 1997 ) Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science, 278, 876 – 878.
dc.identifier.citedreferencePlatt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. ( 1991 ) Pain in sickle cell disease. Rates and risk factors. New England Journal of Medicine, 325, 11 – 16.
dc.identifier.citedreferenceRyan, T.M., Ciavatta, D.J. & Townes, T.M. ( 1997 ) Knockout‐transgenic mouse model of sickle cell disease. Science, 278, 873 – 876.
dc.identifier.citedreferenceSavitt, T.L. & Goldberg, M.F. ( 1989 ) Herrick’s 1910 case report of sickle cell anemia. The rest of the story. Journal of the American Medical Association, 261, 266 – 271.
dc.identifier.citedreferenceSu, E.J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., Gao, Y., Pietras, K., Mann, K., Yepes, M., Strickland, D.K., Betsholtz, C., Eriksson, U. & Lawrence, D.A. ( 2008 ) Activation of PDGF‐CC by tissue plasminogen activator impairs blood‐brain barrier integrity during ischemic stroke. Nature Medicine, 14, 731 – 737.
dc.identifier.citedreferenceThomas, C., Mackey, M.M., Diaz, A.A. & Cox, D.P. ( 2009 ) Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Report, 14, 102 – 108.
dc.identifier.citedreferenceWu, C.J., Krishnamurti, L., Kutok, J.L., Biernacki, M., Rogers, S., Zhang, W., Antin, J.H. & Ritz, J. ( 2005 ) Evidence for ineffective erythropoiesis in severe sickle cell disease. Blood, 106, 3639 – 3645.
dc.identifier.citedreferenceWu, L.C., Sun, C.W., Ryan, T.M., Pawlik, K.M., Ren, J. & Townes, T.M. ( 2006 ) Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood, 108, 1183 – 1188.
dc.identifier.citedreferenceYawn, B.P., Buchanan, G.R., Afenyi‐Annan, A.N., Ballas, S.K., Hassell, K.L., James, A.H., Jordan, L., Lanzkron, S.M., Lottenberg, R., Savage, W.J., Tanabe, P.J., Ware, R.E., Murad, M.H., Goldsmith, J.C., Ortiz, E., Fulwood, R., Horton, A. & John‐Sowah, J. ( 2014 ) Management of sickle cell disease: summary of the 2014 evidence‐based report by expert panel members. JAMA, 312, 1033 – 1048.
dc.identifier.citedreferenceZhang, J., Randall, M.S., Loyd, M.R., Dorsey, F.C., Kundu, M., Cleveland, J.L. & Ney, P.A. ( 2009 ) Mitochondrial clearance is regulated by Atg7‐dependent and ‐independent mechanisms during reticulocyte maturation. Blood, 114, 157 – 164.
dc.identifier.citedreferenceZhang, X., Camprecios, G., Rimmele, P., Liang, R., Yalcin, S., Mungamuri, S.K., Barminko, J., D’Escamard, V., Baron, M.H., Brugnara, C., Papatsenko, D., Rivella, S. & Ghaffari, S. ( 2014 ) FOXO3‐mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. American Journal of Hematology, 89, 954 – 963.
dc.identifier.citedreferenceAliyu, Z.Y., Tumblin, A.R. & Kato, G.J. ( 2006 ) Current therapy of sickle cell disease. Haematologica, 91, 7 – 10.
dc.identifier.citedreferenceAraujo, N.C., Goncalves, Sampaio, de Lucena, S.B. & da Silveira Rioja, S. ( 2014 ) Effect of rapamycin on spleen size in longstanding renal transplant recipients. Transplantation Proceedings, 46, 1319 – 1323.
dc.identifier.citedreferenceCampbell, A.D., Cui, S., Shi, L., Urbonya, R., Mathias, A., Bradley, K., Bonsu, K.O., Douglas, R.R., Halford, B., Schmidt, L., Harro, D., Giacherio, D., Tanimoto, K., Tanabe, O. & Engel, J.D. ( 2011 ) Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes. Proceedings of the National Academy of Sciences of the United States of America, 108, 18808 – 18813.
dc.identifier.citedreferenceChen, S.Y., Wang, Y., Telen, M.J. & Chi, J.T. ( 2008 ) The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One, 3, e2360.
dc.identifier.citedreferenceDeBaun, M.R., Gordon, M., McKinstry, R.C., Noetzel, M.J., White, D.A., Sarnaik, S.A., Meier, E.R., Howard, T.H., Majumdar, S., Inusa, B.P., Telfer, P.T., Kirby‐Allen, M., McCavit, T.L., Kamdem, A., Airewele, G., Woods, G.M., Berman, B., Panepinto, J.A., Fuh, B.R., Kwiatkowski, J.L., King, A.A., Fixler, J.M., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding‐Lallinger, R.C., Kirkham, F.J., Dixon, N., Gonzalez, C.E., Kalinyak, K.A., Quinn, C.T., Strouse, J.J., Miller, J.P., Lehmann, H., Kraut, M.A., Ball, W.S. Jr, Hirtz, D. & Casella, J.F. ( 2014 ) Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. New England Journal of Medicine, 371, 699 – 710.
dc.identifier.citedreferenceDiekmann, F., Rovira, J., Diaz‐Ricart, M., Arellano, E.M., Vodenik, B., Jou, J.M., Vives‐Corrons, J.L., Escolar, G. & Campistol, J.M. ( 2012 ) mTOR inhibition and erythropoiesis: microcytosis or anaemia? Nephrology, Dialysis, Transplantation, 27, 537 – 541.
dc.identifier.citedreferenceDos Santos, T.E., de Sousa, G.F., Barbosa, M.C. & Goncalves, R.P. ( 2012 ) The role of iron overload on oxidative stress in sickle cell anemia. Biomarkers in Medicine, 6, 813 – 819.
dc.identifier.citedreferenceEkberg, H., Bernasconi, C., Noldeke, J., Yussim, A., Mjornstedt, L., Erken, U., Ketteler, M. & Navratil, P. ( 2010 ) Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study. Nephrology, Dialysis, Transplantation, 25, 2004 – 2010.
dc.identifier.citedreferenceFriend, P., Russ, G., Oberbauer, R., Murgia, M.G., Tufveson, G., Chapman, J., Blancho, G., Mota, A., Grandaliano, G., Campistol, J.M., Brault, Y. & Burke, J.T.; Rapamune Maintenance Regimen Study Group ( 2007 ) Incidence of anemia in sirolimus‐treated renal transplant recipients: the importance of preserving renal function. Transplant International, 20, 754 – 760.
dc.identifier.citedreferenceGan, B., Sahin, E., Jiang, S., Sanchez‐Aguilera, A., Scott, K.L., Chin, L., Williams, D.A., Kwiatkowski, D.J. & DePinho, R.A. ( 2008 ) mTORC1‐dependent and ‐independent regulation of stem cell renewal, differentiation, and mobilization. Proceedings of the National Academy of Sciences of the United States of America, 105, 19384 – 19389.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bjh14057.pdf
Size:
588.1KB
Format:
PDF
View/Open
Name:
bjh14057_am.pdf
Size:
306.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.